CME Group Inc. (NASDAQ:CME – Get Free Report) Director Elizabeth Cook sold 500 shares of the business’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $280.11, for a total transaction of $140,055.00. Following the transaction, the director directly owned 17,916 shares of the company’s stock, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
CME Group Stock Down 1.0%
CME stock opened at $272.46 on Thursday. The stock has a market capitalization of $97.97 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 3.25 and a beta of 0.24. The company has a 50-day moving average of $265.75 and a two-hundred day moving average of $276.35. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the company posted $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. As a group, equities research analysts anticipate that CME Group Inc. will post 12.27 EPS for the current year.
CME Group Dividend Announcement
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 29th. UBS Group cut their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their price target for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Finally, The Goldman Sachs Group dropped their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a report on Tuesday, June 30th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $289.75.
Get Our Latest Research Report on CME Group
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Northwestern Mutual Investment Management Company LLC lifted its holdings in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. boosted its holdings in shares of CME Group by 4.4% during the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the last quarter. NBT Bank N A NY grew its position in shares of CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after purchasing an additional 38 shares in the last quarter. Resonant Capital Advisors LLC increased its holdings in shares of CME Group by 3.8% in the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares during the last quarter. Finally, Root Financial Partners LLC lifted its position in shares of CME Group by 13.0% in the fourth quarter. Root Financial Partners LLC now owns 348 shares of the financial services provider’s stock worth $95,000 after buying an additional 40 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
CME Group Company Profile
CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.
The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.
Recommended Stories
- Five stocks we like better than CME Group
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
